Enrolling by Invitation
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
NCT06375993
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +33 more
- Locations
-
- Adicet Clinical Trials Redwood City, California, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States